Stryker Corporation $SYK Stake Raised by Nichols & Pratt Advisers LLP MA

Nichols & Pratt Advisers LLP MA raised its holdings in Stryker Corporation (NYSE:SYK) by 7.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 57,022 shares of the medical technology company’s stock after acquiring an additional 3,856 shares during the quarter. Stryker accounts for about 1.1% of Nichols & Pratt Advisers LLP MA’s portfolio, making the stock its 27th biggest holding. Nichols & Pratt Advisers LLP MA’s holdings in Stryker were worth $17,953,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Norges Bank bought a new stake in shares of Stryker in the 4th quarter worth approximately $1,822,272,000. Bank of America Corp DE bought a new stake in Stryker during the second quarter worth approximately $1,404,284,000. Auto Owners Insurance Co boosted its holdings in Stryker by 35,047.0% during the fourth quarter. Auto Owners Insurance Co now owns 2,914,741 shares of the medical technology company’s stock worth $1,024,444,000 after buying an additional 2,906,448 shares in the last quarter. Legal & General Group Plc acquired a new position in Stryker in the second quarter worth approximately $707,212,000. Finally, Jupiter Topco LLC acquired a new position in Stryker in the second quarter worth approximately $681,581,000. Institutional investors own 77.09% of the company’s stock.

Insiders Place Their Bets

In other Stryker news, insider Dylan Bram Crotty sold 441 shares of the firm’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $328.61, for a total transaction of $144,917.01. Following the completion of the sale, the insider directly owned 6,102 shares in the company, valued at approximately $2,005,178.22. This trade represents a 6.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Ronda E. Stryker sold 50,000 shares of the company’s stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $340.10, for a total value of $17,005,000.00. Following the completion of the transaction, the director owned 2,251,375 shares in the company, valued at $765,692,637.50. This represents a 2.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 351,267 shares of company stock worth $118,197,701. 4.60% of the stock is currently owned by company insiders.

Stryker Price Performance

Shares of NYSE:SYK opened at $331.32 on Friday. The company’s fifty day moving average is $329.10 and its two-hundred day moving average is $331.47. The company has a market cap of $127.08 billion, a P/E ratio of 34.33, a price-to-earnings-growth ratio of 2.11 and a beta of 0.76. Stryker Corporation has a 12-month low of $281.00 and a 12-month high of $396.86. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59.

Stryker (NYSE:SYK) last issued its earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, topping the consensus estimate of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The business had revenue of $6.59 billion during the quarter, compared to analysts’ expectations of $6.58 billion. During the same quarter last year, the firm posted $3.13 earnings per share. Stryker’s revenue was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Equities analysts expect that Stryker Corporation will post 15.02 earnings per share for the current fiscal year.

Stryker Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a $0.88 dividend. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Wednesday, September 30th. Stryker’s dividend payout ratio is currently 36.48%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on SYK shares. Evercore set a $350.00 price objective on Stryker in a research report on Monday, July 6th. Barclays decreased their target price on Stryker from $469.00 to $394.00 and set an “overweight” rating on the stock in a report on Monday, May 4th. Argus set a $370.00 price target on Stryker in a research note on Thursday, July 9th. Citizens Jmp cut their price objective on Stryker from $440.00 to $400.00 and set a “market outperform” rating on the stock in a report on Monday, August 3rd. Finally, BTIG Research reduced their price objective on shares of Stryker from $371.00 to $358.00 and set a “buy” rating for the company in a research note on Friday, July 31st. One research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $386.28.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.